TCL Archive Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial October 31, 2014
TCL Archive Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says February 13, 1998